Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

STRATA Skin Sciences (SSKN) EBIT Margin (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed EBIT Margin for 14 consecutive years, with 5.25% as the latest value for Q4 2025.

  • Quarterly EBIT Margin rose 5000.0% to 5.25% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 15.31% through Dec 2025, up 1226.0% year-over-year, with the annual reading at 15.31% for FY2025, 1226.0% up from the prior year.
  • EBIT Margin hit 5.25% in Q4 2025 for STRATA Skin Sciences, up from 16.93% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 5.25% in Q4 2025 to a low of 44.75% in Q4 2024.
  • Historically, EBIT Margin has averaged 20.38% across 5 years, with a median of 18.43% in 2022.
  • Biggest five-year swings in EBIT Margin: tumbled -4087bps in 2023 and later surged 5000bps in 2025.
  • Year by year, EBIT Margin stood at 6.87% in 2021, then soared by 118bps to 1.26% in 2022, then tumbled by -3233bps to 39.6% in 2023, then dropped by -13bps to 44.75% in 2024, then soared by 112bps to 5.25% in 2025.
  • Business Quant data shows EBIT Margin for SSKN at 5.25% in Q4 2025, 16.93% in Q3 2025, and 30.14% in Q2 2025.